Skip to content

The Evaluation of Pulse: A Mobile Health App and Teen Pregnancy Prevention Program

The Evaluation of Pulse: A Mobile Health App and Teen Pregnancy Prevention Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03253783
Enrollment
1304
Registered
2017-08-18
Start date
2016-11-30
Completion date
2018-01-31
Last updated
2018-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraceptive Usage, Reproductive and Sexual Health Care Utilization, Unprotected Sex

Brief summary

This study uses a randomized controlled design to evaluate the efficacy of a new mobile app, Pulse, in reducing the incidence of unprotected sex among young women. Pulse is a web-based mobile health application that can be accessed through mobile smartphones and computers. Pulse was designed to increase highly effective birth control use and reproductive and sexual health care utilization, and ultimately decrease teen pregnancy. The sample is comprised of women with the following characteristics at study enrollment: aged 18-20, not pregnant or trying to become pregnant, has daily access to a smartphone, currently living in the United States or a U.S. territory, and speaks either English or Spanish. Most of the sample (at least 70%) will be women who identify as Black and/or Latina. The evaluation team plans to enroll up to 1,300 participants over a one-year enrollment period using social media, including Facebook, Instagram, and Twitter. Users access Pulse autonomously, on their own terms, and in their own time and place. The app consists of 6 sections and includes 3 hours of unique content. It does not require the user to follow a specific sequence of content viewed; however, all users will receive a monetary incentive after registering with the apps. Youth randomized to the intervention condition are given access to Pulse indefinitely and receive daily text messages related to sexual health for 6 weeks. Control participants are directed to a free general health/fitness web-based mobile application, also called Pulse, and receive text messages related to general health for 6 weeks. The control and treatment apps look and feel similar aesthetically but contain different content. Participants in both the intervention and comparison groups receive a baseline survey and a 6-week follow-up survey. Participants will also receive incentives once they complete the baseline and post-intervention survey. Both surveys are conducted online via an electronic survey platform. This study is being conducted as a Rigorous Evaluation of New or Innovative Approaches to Prevent Teen Pregnancy funded by the U.S. Department of Health and Human Services' Office of Adolescent Health.

Interventions

BEHAVIORALPulse

Sponsors

Child Trends
CollaboratorOTHER
Ewald and Wasserman
CollaboratorUNKNOWN
Meta Media
CollaboratorUNKNOWN
Healthy Teen Network
Lead SponsorOTHER

Study design

Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 20 Years
Healthy volunteers
Yes

Inclusion criteria

* Gender: Female * Age Limit: 18-20 * Must have daily access to a smartphone that receives text messages and can access to the Internet * Must speak English or Spanish * Must live in the United States or a U.S. territory

Exclusion criteria

* Currently pregnant or trying to get pregnant

Design outcomes

Primary

MeasureTime frameDescription
Unprotected sex, no contraceptive6-week post-baseline (in the past 6 weeks)Ever having sexual intercourse without using any method of contraception (among full sample)
Unprotected sex, no highly effective contraceptive6-week post-baseline (in the past 6 weeks)Ever having sexual intercourse without using a hormonal or LARC method of contraception (among full sample)

Secondary

MeasureTime frameDescription
Reproductive and sexual health care utilization (among full sample)6-weeks post-baselineVisiting a health care provider for reproductive or sexual health services within the past 6 weeks for the 1st follow-up survey

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026